| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |